Status:
COMPLETED
Senescent Immunity in Elders and Vaccine Responses (SILVER)
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Flu Vaccine
Eligibility:
All Genders
65-125 years
Phase:
PHASE4
Brief Summary
To study the effects of age on the immune system's response to flu vaccine and to study the connection between the immune system and physical and cognitive changes associated with aging.
Eligibility Criteria
Inclusion
- Age 65 years and over
- Independent Living (including Assisted Living)
Exclusion
- Unable to understand the consent or the study.
- Allergic to any vaccine components, excluding eggs.
- History of Guillain-Barre.
- Residing in a long -term care facility such as a nursing home.
Key Trial Info
Start Date :
October 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04077424
Start Date
October 21 2019
End Date
February 1 2020
Last Update
July 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37211